Silencing C1GALT1 expression inhibits cancer progression by blocking O-glycan elongation on several growth receptors—e.g., EGFR [13], MET receptor [21], FGFR2 [22], β1-integrin [12,23,24]. This evidence concerns the gene C1GALT1 and cancer.